Skip to main content
. 2022 Nov 30;12:1065934. doi: 10.3389/fonc.2022.1065934

Table 1.

Characteristics of GC patient including for classification modeling.

Characteristics Training cohort (n=526) Internal validation cohort (n=132) P-value External validation cohort (n=93) P-value
Age, mean ± SD, year 61.33 ± 11.30 60.27 ± 10.81 0.333 67.26 ± 9.54 <0.001
Tumor size, mean ± Std, mm 37.94 ± 22.86 41.00 ± 25.08 0.178 40.55 ± 27.09 0.325
Gender, No.(%) 0.047 <0.001
Male 313 (59.51) 91 (68.94) 74 (79.57)
Female 213 (40.49) 41 (31.06) 19 (80.43)
Tumor location, No.(%) 0.316 0.004
Upper-third 93 (17.68) 27 (20.46) 27 (29.03)
Middle-third 158 (30.04) 31 (23.48) 15 (16.13)
Lower-third 275 (52.28) 74 (56.06) 51 (54.84)
Pathological T stage , No.(%) 0.962 0.005
T1 210 (39.92) 53 (40.15) 23 (24.73)
T2-4 316 (60.08) 79 (59.85) 70 (75.27)
Lauren’s classification, No.(%) 0.074 0.006
Intestinal type 301 (57.22) 69 (52.27) 37 (39.78)
Diffuse type 97 (18.44) 36 (27.27) 27 (29.04)
Mixed type 128 (24.34) 27 (20.46) 29 (31.18)
Grade of differentiation, No.(%) 0.604 0.437
Poor/undifferentiated 206 (39.16) 58 (43.94) 43 (46.24)
Moderate 280 (53.23) 65 (49.24) 44 (47.31)
Well 40 (7.61) 9 (6.82) 6 (6.45)
CEA level, No.(%) 0.067 0.518
Negative 488 (92.78) 116 (87.88) 88 (94.62)
Positive 38 (7.22) 16 (12.12) 5 (5.38)
CA12-5 level, No.(%) 0.853 0.382
Negative 504 (95.82) 126 (95.45) 88 (94.62)
Positive 22 (4.18) 6 (4.55) 5 (5.38)
CA19-9 level, No.(%) 0.342 0.004
Negative 445 (84.60) 116 (87.88) 89 (95.70)
Positive 81 (15.40) 16 (12.12) 4 (4.30)

Quantitative variables were in mean ± SD and qualitative variables are in n (%). According to the eighth edition AJCC Cancer Staging Manual. Bold values meant P-value < 0.05.